As of 19 April 2022, an outbreak of 187 confirmed and probable cases of monophasic S. Typhimurium (cluster 1) has been identified in the EU/EEA and the United Kingdom.
On 12 April 2022, ECDC and EFSA published a rapid outbreak assessment on a multi-country outbreak of monophasic Salmonella Typhimurium linked to chocolate products made at a factory in Arlon, Belgium.
EMA and ECDC have reviewed currently available studies and epidemiological data to provide a common position for EU/EEA countries on the current need and potential benefit of a fourth dose (second booster dose) of mRNA COVID-19 vaccines.
ECDC and EMA’s COVID-19 task force (ETF) have concluded that it is too early to consider using a fourth dose of mRNA COVID-19 vaccines (Pfizer’s Comirnaty and Moderna’s Spikevax) in the general population.
Antibiotic resistance in Salmonella and Campylobacter bacteria is still high, says a report released today by the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA).
According to the latest ECDC/WHO report on tuberculosis (TB) surveillance and monitoring in Europe, a sharp drop (24%) in reported tuberculosis cases between 2019 and 2020 was probably exacerbated by the COVID-19 pandemic, which hindered detection and reporting.
Displaced people from Ukraine hosted in reception centres should be offered free access to SARS-CoV-2 testing and vaccination for COVID-19. Additionally, protective measures are recommended by ECDC in the report Guidance for the prevention and control of COVID-19 in temporary reception centres in the context of the displacement of people from Ukraine, published on 18 March.